baber/WOPTO huggingface dataset:
Patent AU-2003277562-B2 (AU)
Title: Pyrazolonaphthyridine derivative
Inventor: NOSE TAKASHI
IPC: A61K31/444
Filed: 2003-11-05
Granted: 2009-03-26
Abstract: The target is to provide PDE IV inhibitors which have a highly potent anti-asthmatic and/or COPD-prophylactic/therapeutic profile with unexpectedly excellent safety. A compound of the formula (1): <CHEM> wherein A is phenyl, pyridyl, 1-oxypyridyl, or thienyl, which may be unsubstituted or optionally substituted with one or more members selected from the group consisting of hydroxyl, halogen, cyano, nitro, lower alkyl, lower alkoxy, lower alkylcarbonyloxy, amino, carboxyl, lower alkoxycarbonyl, carboxy-lower alkylene, lower alkoxycarbonyl-lower alkylene, lower alkylsulfonyl, lower alkylsulfonylamino, and ureido; R<1> is a group selected from the group consisting of hydrogen, hydroxyl, halogen, cyano, nitro, lower alkoxy, amino, carboxyl, and lower alkoxycarbonyl; R<2> is hydrogen or lower alkyl; and m is an integer of 1 to 3; or a pharmaceutically acceptable salt thereof, possesses highly excellent PDE IV-specific inhibitory actions and is useful as an anti-asthmatic drug and/or a prophylactic/therapeutic drug for COPD with high safety.
Patent AU-2005260656-B2 (AU)
Title: Poly (ethylene glycol) - diacrylate- (PEGDA) - crosslinked hydrogels comprising adipogenic mesenchymal stem cells
Inventor: JEREMY MAO
IPC: A61F2/06
Filed: 2005-06-30
Granted: 2011-09-22
Abstract: Methods and compositions for and synthesis of soft tissue in predefined shape and dimensions from adult mesenchymal stem cells (MSC) within a biocompatible scaffold are described. Scaffolds are implanted in a host animal and fabricated therein, or maintained . Inducing angiogenesis enhances success of soft tissue implants.
Patent AU-2006202410-B2 (AU)
Title: A device for demarcating an area
Inventor: KUILENBURG JAN MARTINUS VAN
IPC: A01K3/00
Filed: 2006-06-07
Granted: 2011-05-12
Abstract: The invention relates to a device for demarcating an area, in particular for limiting the freedom of movement of animals walking about freely. The device according to the invention is provided with a demarcating element (2) that is connected with a first vehicle (1) and with at least a second vehicle (10), and at least a first vehicle (1) being provided with a tracking arm structure (3) for making it possible to track a guide element (4) disposed in the area, such as for example a wire fencing. The demarcating element (2) is disposed in a stretched position between the two vehicles (1, 10) in such a way that the demarcating element (2) does not exert force on the tracking arm structure (3).
Patent AU-2006230752-B2 (AU)
Title: Lumen traversing device
Inventor: ORTIZ MARK
IPC: A61B17/94
Filed: 2006-10-20
Granted: 2013-09-19
Abstract: Various exemplary methods and devices are provided for traversing a lumen, such as the gastrointestinal tract. The devices can include an elongate body having distally positioned tubing elements and proximally positioned control elements. The tubing elements are adapted for selective and independent radial expansion and contraction and longitudinal movement, such that movement of the tubing elements can drive the device through a lumen. In addition, the tubing elements can include a traction surface to reduce slippage. -JL (-'j '--4
Patent AU-2006246037-B2 (AU)
Title: Process and system for the disposal of excretion containers
Inventor: STREB MICHAEL
IPC: A61G9/02
Filed: 2006-04-27
Granted: 2010-11-18
Abstract: Particularly in hospitals, care homes or similar institutions, it is necessary to have a safely handled and reliable method for the emptying and cleaning of excretion containers, for example urine bottles or bedpans. A method and a system (110) are therefore proposed, by means of which such articles to be rinsed (112) can be treated. In this case, first, in an emptying step (210), the articles to be rinsed (112) are emptied and are rinsed out with a rinsing-out liquid. Subsequently, in a circulation step (212), the articles to be rinsed (112) are washed in circulation. Finally, a rinsing-clear step (214) is carried out, in which the articles to be rinsed (112) are rinsed with a rinsing-clear liquid. Then, in an optional disinfection step (216), preferably a chemical disinfection step (216), the articles to be rinsed (112) are disinfected, and, in an optional drying step (218), the articles to be rinsed (112) are dried by being blown off with heated air.
Patent AU-2006258052-B2 (AU)
Title: Medical stapler
Inventor: SURTI VIHAR C
IPC: A61B17/064
Filed: 2006-06-07
Granted: 2012-02-09
Abstract: A stapler for delivering a staple formed from a shape memory material is disclosed. The staple includes a first tine and a second tine connected by a bridge. The staple may be disposed within the stapler in an open position with the first tine distal of the second tine. The stapler is configured to sequentially deliver the first tine and the second tine, respectively, to opposing body tissues. The stapler includes an elongate shaft (e.g., a catheter) having a working lumen and a control mechanism for delivering the staple. A drive cable extends along the working lumen of the elongate shaft. Upon warming up to a temperature at or above a transformation temperature of the shape memory material, the staple may assume a closed position, thus drawing together opposing body tissues and closing an incision.
Patent AU-2006274862-B2 (AU)
Title: Macrocyclic inhibitors of hepatitis C virus
Inventor: SAMUELSSON BENGT BERTIL
IPC: C07D413/12
Filed: 2006-07-28
Granted: 2012-03-22
Abstract: Inhibitors of HCV replication of formula (I) and the -oxides, salts, or stereoisomers thereof, wherein each dashed line represents an optional double bond; X is N, CH and where X bears a double bond it is C; R is -OR, -NH-SOR; Ris hydrogen, and where X is C or CH, R may also be Calkyl; R is hydrogen, Calkyl, CalkoxyCalkyl, or Ccycloalkyl; n is 3, 4, 5, or 6; R and R taken together with the nitrogen atom to which they are attached form a bicyclic ring system selected from formula (II) wherein said ring system may optionally be substituted with 1-3 substituents; R is hydrogen; aryl; Het; Ccycloalkyl optionally substituted with Calkyl; or Calkyl optionally substituted with Ccycloalkyl, aryl or with Het; Ris aryl; Het; Ccycloalkyl optionally substituted with Calkyl; or Calkyl optionally substituted with Ccycloalkyl, aryl or with Het; aryl is phenyl or naphthyl, each of which may be optionally substituted with 1-3 substituents; Het is a 5 or 6 membered saturated, partially unsaturated or completely unsaturated heterocyclic ring containing 1 to 4 heteroatoms each independently selected from N, O or S, and being optionally substituted with 1-3 substituents pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I). Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.
Patent AU-2006297251-B2 (AU)
Title: Compact-folded article and pouch
Inventor: HECK ANGELA RAE
IPC: A61F13/551
Filed: 2006-09-28
Granted: 2012-08-16
Abstract: A personal care article (20) has a longitudinal-direction (22), a relatively shorter, lateral cross-direction (24), a first end-section (72), a second end-section (72a), and an intermediate-section (76) which is contiguous with and interposed between the first end-section (72) and the second end-section (72a). The article includes a liquid permeable topsheet layer (26), and a backsheet layer (28) which is operatively connected to the topsheet layer (26). The article has been folded about a first, supplemental-fold-region (64) and a second, supplemental-fold-region (66) to provide a preliminary-folded article (82). The preliminary-folded article has been operatively enclosed in a wrap member (98), and the preliminary-folded article and wrap member have been folded along a composite- fold-region (96a) to provide a composite-folded, wrapped-article (114). The wrap member has included a wrap retainer mechanism (112) which has been configured to operatively hold the composite-folded, article and wrap member in their composite-folded condition.
Patent AU-2006332008-B2 (AU)
Title: Catalysts and methods for reforming oxygenated compounds
Inventor: HORNEMANN CHARLES C
IPC: B07C1/20
Filed: 2006-12-18
Granted: 2012-09-06
Abstract: Disclosed are catalysts and methods that can reform aqueous solutions of oxygenated compounds such as ethylene glycol, glycerol, sugar alcohols, and sugars to generate products such as hydrogen and alkanes. In some embodiments, aqueous solutions containing at least 20 wt% of the oxygenated compounds can be reformed over a catalyst comprising a Group VIII transition metal and a Group VIIB transition metal, preferably supported on an activated carbon-supported catalyst. In other embodiments, catalysts are provided for the production of hydrogen or alkanes at reaction temperatures less than 300C.
Patent AU-2007248282-B2 (AU)
Title: Crystalline (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone phosphate
Inventor: ALAN STEPHENSON GREGORY
IPC: C07D209/42
Filed: 2007-04-24
Granted: 2011-12-08
Abstract: The present invention relates to novel crystalline forms of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl] methanone phosphate and to pharmaceutical compositions containing said forms. X-17526M
Patent AU-2007284033-B2 (AU)
Title: Implantable medical cuff with electrode array
Inventor: BLUGER HENRY
IPC: A61N1/375
Filed: 2007-08-14
Granted: 2012-02-02
Abstract: An implantable medical assembly comprising at least one electrode carried on an inside surface of a web comprising a biocompatible film wound into a generally tubular configuration, the film containing at least one aperture through the web to increase its flexibility and to create a means by which biological fluids can penetrate the assembly. The assembly may further comprise at least one wire connected to the electrode to provide a stimulation signal.
Patent AU-2007284851-B2 (AU)
Title: Crystalline antifungal compounds
Inventor: LORIMER KEITH
IPC: A61P33/02
Filed: 2007-08-06
Granted: 2013-05-09
Abstract: Novel crystalline forms of (1R,2R)-7-chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one, pharmaceutical compositions containing these crystalline forms, methods of using these crystalline forms for treating and/or preventing various microbial and/or fungal infections or disorders, and processes for obtaining these crystalline forms. In particular, the present subject matter relates to the specific crystalline Forms I, II, III, IV, V, and VI of (1R, 2R)-7-chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one.
Patent AU-2007312227-B2 (AU)
Title: Process for manufacturing an asphalt paving mixture
Inventor: DEME IMANTS
IPC: C04B22/02
Filed: 2007-10-18
Granted: 2010-11-18
Abstract: A process for manufacturing an asphalt paving mixture is disclosed. The process comprises the steps of: (i) heating bitumen at a temperature of from 100 to 200° C.; (ii) heating aggregate at a temperature of from 100 to 200° C.; and (iii) mixing the hot bitumen with the hot aggregate in a mixing unit. From 10 to 200 wt % of sulphur pellets, based upon the weight of the bitumen, are added in at least one of the steps (i), (ii) or (iii). The sulphur pellets comprise from 1 to 50 wt % of a monovinyl aromatic compound, based upon the weight of the sulphur pellets.
Patent AU-2007323541-B2 (AU)
Title: Methods of treating chronic inflammatory diseases using a GM-CSF antagonist
Inventor: YARRANTON GEOFFREY T
IPC: A61K39/00
Filed: 2007-11-21
Granted: 2012-01-19
Abstract: The invention is based on the discovery that GM-CSF antagonists can be used for the treatment of chronic inflammatory disease, such as rheumatoid arthirtis. Accordingly, the invention provides methods of administering a GM-CSF antagonist, e.g., a GM-CSF antibody, and an anti-folate compounds, e.g., methotrexate, to a patient that has RA and pharmaceutical compositions comprising such antagonists.
Patent AU-2007329676-B2 (AU)
Title: Designed degradable cage coated with mineral layers for spinal interbody fusion
Inventor: MURPHY WILLIAM L
IPC: A61F2/44
Filed: 2007-10-30
Granted: 2013-10-10
Abstract: A cage for facilitating fusion of bones, such as vertebrae, or fusion of adjacent bone surfaces is disclosed. In one form, the cage includes a plurality of spaced apart walls comprising a biodegradable polymeric material (e.g., polycaprolactone); an osteoconductive mineral coating (e.g., a calcium compound) on at least a portion of the walls; and a bioactive agent (e.g., a bone morphogenetic protein) associated with the polymeric material and/or the coating The bioactive agent is present in amount that induces ossification between the bones or adjacent bone surfaces. The cage may also include a fixation plate connected to at least one of the walls.
Patent AU-2008217539-B2 (AU)
Title: Brewing apparatus and method
Inventor: WALLACE ALLAN K
IPC: G01K1/02
Filed: 2008-02-22
Granted: 2013-09-12
Abstract: The specification discloses brewing apparatus and a method for testing for end of fermentation of a fermenting brew. It has been determined that, once fermentation is complete, the temperature of a brew (such as beer) shows a tendency to stratify in horizontal layers. However, the activity of fermentation disrupts the tendency of the brew to stratify. Accordingly, the brewing apparatus comprises at least two temperature sensors positioned to measure a temperature difference between the temperature at a first height of the brew and the temperature at a second height of the brew. End of fermentation is identified if the temperature difference is greater than a threshold difference.
Patent AU-2008236615-B2 (AU)
Title: Improved methods and compositions for determining the pathogenic status of infectious agents
Inventor: MULVEY MATTHEW C
IPC: C07H21/04
Filed: 2008-04-07
Granted: 2013-10-03
Abstract: Methods and compositions for the detection of disease caused by infectious agents and microbes are provided. In particular, methods and compositions comprising novel combinations of nucleic acid amplification and drug susceptibility technologies are provided. In certain embodiments, the present invention enables the detection of infectious agents and microbes as well as providing information concerning the viability status of the agent or microbe. In one embodiment, the present invention is used for the detection of mycobacterial infections, including, but not limited to, tuberculosis.
Patent AU-2008237593-B2 (AU)
Title: Data processing apparatus and method
Inventor: TAYLOR MATTHEW PAUL ATHOL
IPC: H04L27/26
Filed: 2008-10-29
Granted: 2012-04-05
Abstract: DATA PROCESSING APPARATUS AND METHOD A data processing apparatus maps input symbols to be communicated onto a predetermined number of sub-carrier signals of an Orthogonal Frequency Division Multiplexed (OFDM) symbol. The data processor includes an interleaver memory (100) which reads-in the predetermined number of data symbols for mapping 5 onto the OFDM sub-carrier signals. The interleaver memory (100) reads-out the data symbols on to the OFDM sub-carriers to effect the mapping, the read-out being in a different order than the read-in, the order being determined from a set of addresses, with the effect that the data symbols are interleaved on to the sub-carrier signals. The set of addresses are generated from an address generator (102) which comprises a 10 linear feedback shift register (200) and a permutation circuit (210). The linear feedback shift register (200) has ten register stages with a generator polynomial for the linear feedback shift register of R;[9] = R; _[0)C R 1 _[3], and the permutation code forms, with an additional bit, an eleven bit address. The permutation code is changed from one OFDM symbol to another, thereby providing an improvement in interleaving 15 the data symbols for a 2K operating mode of an OFDM modulated system such as a Digital Video Broadcasting (DVB) standard such as DVB-Terrestrial2 (DVB-T2). This is because there is a reduced likelihood that successive data bits which are close in order in an input data stream are mapped onto the same sub-carrier of an OFDM symbol. [Fig. 5] tt -0 It ULU C0) c - U C) ccc)-? Mm.~'< 000 C~q- a :-2,-
Patent AU-2008239213-B2 (AU)
Title: Oil-based white ink for inkjet recording and method for producing the same
Inventor: TAMURA MITSUYOSHI
IPC: C09K23/00
Filed: 2008-03-26
Granted: 2013-06-20
Abstract: Disclosed is an oil-based white ink composition for inkjet recording. The oil-based white ink composition contains a white pigment, a glycol ether dialkyl ether solvent, a polymer dispersing agent, and a specific acrylic resin. The white pigment is obtained by further coating titanium oxide particles, which have an average particle diameter of not less than 0.15 μm but not more than 0.25 μm and are coated with an oxide of aluminum and/or silicon, with not less than 0.01% by mass but not more than 2.5% by mass of an SiH-containing polysiloxane and/or dimethylpolysiloxane.
Patent AU-2008266378-B2 (AU)
Title: System and method for integrating and displaying travel advices gathered from a plurality of reliable sources
Inventor: NATH GOURABMOY
IPC: G06Q50/00
Filed: 2008-06-05
Granted: 2012-05-17
Abstract: A computerized travel system and a method for providing advices and warnings per travel destination to end-users of the travel systemare described. System of the invention has aclient service module aimed at receiving queries from the end-users,and at delivering to them merged reports of travel advices and warnings for the queried travel destinations. Adownload and parsing module is used to parse travel raw documents,downloaded from a plurality of online reliable travel sources, into cleaned raw documents sharing a common formatting structure including sections, sections headers and paragraphs. An algorithmic module integrates the cleaned raw documents into the merged reports of travel advices and warnings per travel destination. The integration of the cleaned raw documents into merged reports is performed from a base document chosen among all the relevant clean raw documents for each queried travel destination.Comparable sections are determined on the basis of contents of their section headers and semantically close paragraphs are placed next to each other in the corresponding sections of the merged reports.
Patent AU-2008324183-B2 (AU)
Title: Multilayer rotomoulded articles
Inventor: MAZIERS ERIC
IPC: B29C41/04
Filed: 2008-11-04
Granted: 2012-05-03
Abstract: This invention relates to the field of multilayer articles prepared by rotational moulding with a robotised rotomoulding machine wherein the mould is under direct heating.
Patent AU-2009215329-B2 (AU)
Title: Combination comprising paclitaxel for treating ovarian cancer
Inventor: REGENASS URS
IPC: A61K45/06
Filed: 2009-02-19
Granted: 2014-08-21
Abstract: The invention relates to the combination of an endothelin receptor antagonist of formula (I) with paclitaxel, and in particular to this combination for therapeutic use, simultaneously, separately or over a period of time, in the treatment of ovarian cancer.
Patent AU-2009264387-B2 (AU)
Title: Absorption medium and method for removing sour gases from fluid streams, in particular from flue gases
Inventor: VOGES SUSANNA
IPC: B01D53/62
Filed: 2009-06-09
Granted: 2014-01-09
Abstract: Absorption medium for sour gases, comprising an oligoamine (A) of the general formula (I) and a primary or secondary alkanol amine (B) of the general formula (II), in which the weight ratio of oligoamine (A) to primary or secondary alkanol amine (B) is 0.2 to 4, and a method for removing sour gases from a gas stream by contacting the gas stream at a pressure of 0.05 to 10 MPa abs with an aqueous solution of said absorption medium, said solution being temperature-controlled at a temperature of 20 to 80°C.
Patent AU-2009268528-B2 (AU)
Title: Functional micelles for hard tissue targeted delivery of chemicals
Inventor: LI XUE
IPC: A61K31/66
Filed: 2009-07-09
Granted: 2015-11-05
Abstract: Compositions and methods for targeting agents to hard tissue are provided comprising A method includes administering to a subject a composition compπsing micelles, the micelles compπsing at least one amphiphilic block copolymer linked to at least one tooth targeting moiety The composition further includes at least one encapsulated compound and is provided in a pharmaceutically acceptable carrier
Patent AU-2009291825-B2 (AU)
Title: Microorganisms for the production of 1,4-butanediol
Inventor: BURK MARK J
IPC: C12P7/16
Filed: 2009-09-09
Granted: 2016-05-05
Abstract: The invention provides non- naturally occurring microbial organisms comprising a 1,4-butanediol (BDO) pathway comprising at least one exogenous nucleic acid encoding a BDO pathway enzyme expressed in a sufficient amount to produce BDO. The invention additionally provides methods of using such microbial organisms to produce BDO.
Patent AU-2009297493-B2 (AU)
Title: Carbonated drink having high gas pressure
Inventor: IDO YOSHIHIRO
IPC: A23L2/00
Filed: 2009-09-29
Granted: 2015-02-05
Abstract: Provided is a carbonated drink having a high gas pressure and showing an increased drinkability which has improved bubble qualities, is packed in a container provided with a resealable cap and can sustain a stimulating feeling, light taste and refreshing coolness characteristic to carbonated drinks having high gas pressure even in the case where it is stored after opening the container and then resealing. A packed carbonated drink containing at least one kind of condensed phosphate which has a condensed phosphate concentration of 50 ppm to 2000 ppm inclusive and a gas pressure is 2.0 to 5.0 kg/cm
Patent AU-2009311697-B2 (AU)
Title: Methods and compositions for inactivating glutamine synthetase gene expression
Inventor: LIU PEI-QI
IPC: C12P21/06
Filed: 2009-10-29
Granted: 2014-12-18
Abstract: Disclosed herein are methods and compositions for inactivating a glutamine synthetase (GS) gene, using fusion proteins comprising a zinc finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding said fusion proteins are also provided, as are cells comprising said polynucleotides and fusion proteins.
Patent AU-2010202980-B2 (AU)
Title: System and method for ordering and delivering media content using supplementary data which is transmitted with a broadcast signal
Inventor: THOMAS BARRY D
IPC: H04H20/34
Filed: 2010-07-14
Granted: 2014-01-23
Abstract: C \NRPortb\DCCKLL1*.U446-I DOC-34/2010 An Automatic Purchase System (APS) provides a radio broadcast listener with the ability to conveniently purchase media content such as music or speech while listening to the radio. The user can respond to items 5 in the radio broadcast such as advertisements, fund raising drives such as those conducted by public radio, or interactive listener polls during the broadcast. Data such as song title and artist, author or publisher and the IP address for the location where the digital version of the content is stored, can be transmitted using the RBDS/RDS data stream. A reference number representing song title and artist, author or publisher and the IP address for the location where the digital version of the content is stored can also be employed for ease of 10 implementation. This reference number can reside in a lookup table to be accessed by the APS server software on a Data Server located at the broadcast site, a remote site or both for purposes of redundancy. Transmission of purchase requests from a Technology Enabled Radio (TER) is provided via wireless transmission, or by accessing the Internet using a personal computer or through a cellular or wireless phone. z3 0ofl 'C'~I wj z 0u m Lu C C!,3